Acute Leukemia of Ambiguous Lineage in Relapse
Oncology·MeSH: Leukemia, Myeloid, Acute
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| Filgrastim | AbbVie Inc. (ABBV) |
Frequently asked questions
How many drugs are in development for Acute Leukemia of Ambiguous Lineage in Relapse?
BioSniper tracks 1 drug in development for Acute Leukemia of Ambiguous Lineage in Relapse across 1 company.
How many clinical trials target Acute Leukemia of Ambiguous Lineage in Relapse?
There are 2 clinical trials targeting Acute Leukemia of Ambiguous Lineage in Relapse tracked by BioSniper.
Deep-dive into Acute Leukemia of Ambiguous Lineage in Relapse
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis